Concepedia

Lingjian Kong

LK

Statistics

Publications

3

Citations

149

H-Index

3

Active since

2013

Affiliations

Second Affiliated Hospital of Harbin Medical University(Current)

Harbin Medical University

Lingjian Kong is an author at Second Affiliated Hospital of Harbin Medical University specializing in molecular pharmacology, pharmacology, and fibrosis.

Publications per year

2013–2017

3

Publications

3

Tunneling endoscopic muscularis dissection for subepithelial tumors originating from the muscularis propria of the esophagus and gastric cardia

Bing-Rong Liu, Ji-Tao Song, Lingjian Kong et al. · Surgical Endoscopy · 2013 · 94 citations

, , +17

Vatalanib, a tyrosine kinase inhibitor, decreases hepatic fibrosis and sinusoidal capillarization in CCl4-induced fibrotic mice

Lingjian Kong, Hao Li, Ya-Ju Du et al. · Molecular Medicine Reports · 2017 · 33 citations · Full text

, , +16

Endostar, a novel human recombinant endostatin, attenuates liver fibrosis in CCl <sub>4</sub> -induced mice

Jing Chen, Dian-gang Liu, Guang Yang et al. · Experimental Biology and Medicine · 2014 · 22 citations

, , +17

1–3 of 3